Literature DB >> 17292567

Immunogenicity and haemagglutination of recombinant Avibacterium paragallinarum HagA.

Yuan-Man Hsu1, Happy K Shieh, Wei-Hao Chen, Jia-Hsiang Shiang, Poa-Chun Chang.   

Abstract

Inactivated vaccines of Avibacterium paragallinarum provide protection and reduce the economic losses caused by infectious coryza. However, inactivated bacterins provide protection only against the Page serovars included in the vaccine. In this study, we investigated the immunological properties of a functional recombinant haemagglutinin protein (rHagA) derived from a Taiwan isolate strain A9 as the immunogen for vaccination. The rHagA subunit vaccine protected 71% of immunized chickens against 10(10) colony-forming units (CFU) of viable A9. Vaccinated chickens which showed no clinical signs of coryza developed haemagglutination inhibition (HI) titers of 1:10 or greater. Haemagglutination (HA) of serovars A and C was not affected by the presence of rHagA specific antiserum. The HA of rHagA could only be induced against formaldehyde-fixed chicken red blood cells (FA-RBCs). These results suggested that HagA is a moderate immunogen and might not be a major haemagglutinin in vivo. However, HagA might be involved in haemagglutination when treated serovar C aggregates fixed RBCs in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292567     DOI: 10.1016/j.vetmic.2007.01.014

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  2 in total

1.  Efficacy of tetravalent coryza vaccine against the challenge of Avibacterium paragallinarum serovars A and B isolates from Indonesia in chickens.

Authors:  Agnesia Endang Tri Hastuti Wahyuni; Dhasia Ramandani; Vinsa Cantya Prakasita; Sitarina Widyarini
Journal:  Vet World       Date:  2019-07-05

2.  Characterization of emergent Avibacterium paragallinarum strains and the protection conferred by infectious coryza vaccines against them in China.

Authors:  Yang Xu; Jinlong Cheng; Xiuying Huang; Meiyu Xu; Jinling Feng; Changqing Liu; Guozhong Zhang
Journal:  Poult Sci       Date:  2019-12-01       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.